Total Payments
$13,672
2024 Payments
$4,175
Companies
54
Transactions
729
Medicare Patients
5,843
Medicare Billing
$592,860
Payment Breakdown by Category
Food & Beverage$13,092 (95.8%)
Education$580.37 (4.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,092 | 710 | 95.8% |
| Education | $580.37 | 19 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,898 | 200 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,455 | 84 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $1,427 | 44 | $0 (2024) |
| Biogen, Inc. | $980.23 | 57 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $961.76 | 58 | $0 (2024) |
| Lilly USA, LLC | $784.93 | 38 | $0 (2024) |
| Allergan, Inc. | $485.56 | 38 | $0 (2022) |
| SK Life Science, Inc. | $434.42 | 22 | $0 (2024) |
| MDD US Operations, LLC | $379.48 | 8 | $0 (2024) |
| Genentech USA, Inc. | $354.18 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,175 | 189 | ABBVIE INC. ($841.61) |
| 2023 | $3,190 | 179 | AbbVie Inc. ($656.39) |
| 2022 | $2,008 | 97 | ABBVIE INC. ($773.52) |
| 2021 | $1,817 | 117 | AbbVie Inc. ($610.86) |
| 2020 | $920.79 | 63 | Allergan, Inc. ($209.22) |
| 2019 | $576.38 | 36 | Teva Pharmaceuticals USA, Inc. ($157.14) |
| 2018 | $415.07 | 16 | Teva Pharmaceuticals USA, Inc. ($189.80) |
| 2017 | $570.00 | 32 | Sunovion Pharmaceuticals Inc. ($211.66) |
All Payment Transactions
729 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Immune | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: Neurology | ||||||
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: Neurology | ||||||
| 11/20/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $40.68 | General |
| Category: Immune | ||||||
| 11/20/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: Immune | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $27.77 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: PAIN | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $49.29 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,489 | 12,306 | $550,674 | $177,307 |
| 2022 | 27 | 1,493 | 9,193 | $526,143 | $167,177 |
| 2021 | 23 | 1,474 | 1,817 | $368,255 | $132,820 |
| 2020 | 25 | 1,387 | 1,864 | $361,101 | $115,556 |
Total Patients
5,843
Total Services
25,180
Medicare Billing
$592,860
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 25 | 10,465 | $125,580 | $44,596 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 288 | 449 | $102,821 | $41,642 | 40.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 114 | $34,998 | $15,603 | 44.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 166 | 234 | $36,738 | $15,569 | 42.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 107 | 107 | $38,413 | $13,086 | 34.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 73 | 109 | $50,140 | $8,826 | 17.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 17 | 17 | $16,269 | $6,317 | 38.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $12,068 | $3,993 | 33.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $10,189 | $3,708 | 36.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 26 | 26 | $26,000 | $3,688 | 14.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 15 | 15 | $18,750 | $2,584 | 13.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 11 | 11 | $16,500 | $2,250 | 13.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 16 | 27 | $4,455 | $1,691 | 38.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 15 | 15 | $11,250 | $1,662 | 14.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 102 | 104 | $8,008 | $1,537 | 19.2% |
| 82746 | Folic acid level, serum | Office | 2023 | 101 | 102 | $7,854 | $1,470 | 18.7% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 26 | 27 | $4,725 | $1,391 | 29.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 129 | 164 | $3,280 | $1,370 | 41.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 18 | 19 | $3,401 | $1,345 | 39.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 12 | $2,616 | $1,160 | 44.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 12 | 12 | $2,430 | $1,152 | 47.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 42 | 42 | $3,612 | $691.32 | 19.1% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 17 | 51 | $3,009 | $576.30 | 19.2% |
| 86038 | Screening test for autoimmune disorder | Office | 2023 | 28 | 29 | $1,798 | $343.65 | 19.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 12 | 12 | $1,824 | $323.76 | 17.8% |
About Dr. Christopher Simon, MD
Dr. Christopher Simon, MD is a Neurology healthcare provider based in Hinsdale, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962481440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Simon, MD has received a total of $13,672 in payments from pharmaceutical and medical device companies, with $4,175 received in 2024. These payments were reported across 729 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($13,092).
As a Medicare-enrolled provider, Simon has provided services to 5,843 Medicare beneficiaries, totaling 25,180 services with total Medicare billing of $592,860. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Hinsdale, IL
- Active Since 01/12/2006
- Last Updated 08/22/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1962481440
Products in Payments
- UBRELVY (Drug) $1,996
- KESIMPTA (Drug) $825.50
- TYSABRI (Biological) $758.21
- BOTOX (Biological) $618.61
- Qelbree (Drug) $583.49
- EMGALITY (Drug) $579.94
- AJOVY (Biological) $549.04
- QULIPTA (Drug) $440.36
- Apokyn (Drug) $311.22
- Austedo XR (Drug) $247.96
- AJOVY (Drug) $233.69
- AMYVID (Drug) $204.99
- NURTEC ODT (Drug) $196.71
- Nourianz (Drug) $182.64
- BAFIERTAM (Drug) $182.53
- AUSTEDO (Drug) $181.31
- VUMERITY (Drug) $174.12
- OCREVUS (Biological) $171.97
- ZEPOSIA (Drug) $153.45
- FYCOMPA (Drug) $148.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Hinsdale
Rizwan Bajwa, Do, DO
Neurology — Payments: $347,958
Neurology $347,958
Craig Wlodarek, M.d, M.D
Neurology — Payments: $24,872
Neurology $24,872
Eva Pilcher, Md, MD
Neurology — Payments: $13,755
Neurology $13,755
Dr. Michael Boyd, M.d, M.D
Neurology — Payments: $9,234
Neurology $9,234
Dr. Zeina Rabi, M.d, M.D
Neurology — Payments: $6,560
Neurology $6,560
Staci Graf, M.d, M.D
Neurology — Payments: $875.27
Neurology $875.27